BGT007H
/ Biosyngen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 27, 2024
Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
(clinicaltrials.gov)
- P=N/A | N=12 | Recruiting | Sponsor: RenJi Hospital
New trial • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1